FdaApplication

BLA 761235

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGenentech, Inc.
application_typeBLA
approval_date2022-01-28

Products (2)

ProductActive ingredientStrengthDosage form
VABYSMOFARICIMAB-SVOA6MG/0.05ML (120MG/ML)INJECTABLE;INTRAVITREAL
VABYSMO—6MG/0.05ML (120MG/ML)Injection

2 products